Summary- Five year follow-up data show FOTIVDA® (tivozanib) patients up to 5X more likely to experience long-term PFS compared to Nexavar® (sorafenib)…
SUMMARY – Last year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by the name of Cabenuva was…
Synopsis : Granules India Ltd on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed…
Synopsis : Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of…
Summary : Vigabatrin is used to treat babies, one month to two years old with infantile spasms. Zydus has received final approval…
Summary : The drug, to be available under the brand name Quviviq, was approved in doses of 25 mg and 50 mg…
Synopsis: Jubilant Therapeutics Inc, a biopharmaceutical company, announced US Food and Drug Administration (FDA) clearance of the investigational new drug application (IND)…
Blueprint Medicines Corporation a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective on…
Summary : – Expands Blueprint Medicines’ lung cancer pipeline with LNG-451, a highly selective brain-penetrant precision therapy targeting EGFR exon 20 insertion…
Summary : Granules India on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed salts…